Our response to the crisis in Ukraine

Published on March 10, 2022

Our response to the crisis in Ukraine We strongly condemn the war being waged against Ukraine, a sovereign European nation, and stand with the international community in calling for peace. As a company we have already announced our initial commitment of €1 million in immediate funds to provide aid to refugees, and we are matching our employees' donations. So far, our colleagues have donated more than € 800,000. Our top priority is the safety and well-being of our colleagues in the Ukraine and their families, and we are doing all we can to help them.

Siemens Healthineers 2022

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com.